Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of σ70 domain 1.1
See allHide authors and affiliations
Edited by E. Peter Geiduschek, University of California, San Diego, La Jolla, CA, and approved October 15, 2013 (received for review August 1, 2013)

Significance
After infection of Escherichia coli by bacteriophage T7, the host RNA polymerase (RNAP) produces early phage transcription products that encode the phages own RNAP (that transcribes subsequent phage genes) as well as Gp2, an essential inhibitor of the host RNAP. X-ray crystal structures of E. coli RNAP define the structure and location of the RNAP σ70 subunit domain 1.1 inside the RNAP active site channel, where it must be displaced by the DNA upon formation of the transcription complex. Gp2 binds inside the RNAP active site channel and also interacts with
, preventing
from exiting the RNAP active site channel. Gp2 thus misappropriates a domain of the RNAP,
, to inhibit the function of the enzyme.
Abstract
Bacteriophage T7 encodes an essential inhibitor of the Escherichia coli host RNA polymerase (RNAP), the product of gene 2 (Gp2). We determined a series of X-ray crystal structures of E. coli RNAP holoenzyme with or without Gp2. The results define the structure and location of the RNAP σ70 subunit domain 1.1 inside the RNAP active site channel, where it must be displaced by the DNA upon formation of the open promoter complex. The structures and associated data, combined with previous results, allow for a complete delineation of the mechanism for Gp2 inhibition of E. coli RNAP. In the primary inhibition mechanism, Gp2 forms a protein–protein interaction with
, preventing the normal egress of
from the RNAP active site channel. Gp2 thus misappropriates a domain of the RNAP holoenzyme,
, to inhibit the function of the enzyme.
After infection of Escherichia coli by bacteriophage T7 (1), the first T7 genomic DNA to enter the bacterial cell contains four strong, early promoters transcribed by the host RNA polymerase (RNAP) σ70-holoenzyme (E-σ70). An early transcription product is T7 gene 1, coding for the single-subunit T7 RNAP that transcribes the middle and late phage genes. There appears to be no function for E. coli RNAP in middle and late infection, and indeed T7 encodes an essential inhibitor of E. coli RNAP, the 7.2-kDa product of gene 2 (Gp2). The essential role of Gp2 in T7 infection is to prevent unregulated transcription of the phage genome by the host RNAP in late stages of infection, which interferes with transcription of the phage genome by the speedier T7 RNAP (2). The requirement to shut off E. coli RNAP transcription is stringent. Gp2 is accordingly a potent inhibitor of E-σ70 transcription initiation (3, 4).
Gp2 binds to E-σ70 with sub-nanomolar Kd (5). The major binding determinant for Gp2 on the RNAP is the β′-jaw domain (Fig. 1) (4, 5). NMR structures of Gp2 and a Gp2–β′-jaw subcomplex, as well as molecular models of the Gp2–E-σ70 complex, indicate that Gp2 occupies a part of the RNAP downstream duplex DNA channel (5⇓–7). Gp2 blocks the formation of the open promoter complex (RPo), but preformed RPo and RNAP elongation complexes (where the downstream duplex DNA already occupies the channel) are resistant to Gp2 (4, 6), suggesting a straightforward mechanism whereby Gp2 binding or downstream duplex DNA binding in the RNAP downstream channel are mutually exclusive. However, this mechanism does not explain observations that RNAP harboring an N-terminal truncation of domain 1.1 of σ70 (Δ1.1σ70; Fig. 1A) is very inefficiently inhibited by Gp2 (5, 7), indicating a more complex inhibition mechanism for Gp2.
Structure of E. coli E-σ70. (A) Structural architecture of E. coli σ70. The top bar represents the primary sequence of E. coli σ70 (residues 1–613). Every 100 residues are labeled on the bottom and marked with a thin white vertical line. The domain architecture is denoted by the thickness of the horizontal bar; thick regions represent structural domains (,
,
, and
) and thin regions represent flexible loop regions (16). Hollow white regions denote disordered loops. The structural core of
and the linker connecting
with
are colored dark orange. The rest of σ70 is colored light orange except the nonconserved region σ70 (σ70NCR) (NCR inserted between conserved sequence regions 1.2 and 2.1) is colored light yellow (17, 29). The expanded view below denotes the secondary structure of
and the
linker (the thin line represents loop regions with dashed lines representing disordered segments not modeled; rectangles represent α-helices numbered α1–α3 in the σ701.1 structural core). The modeled portion of
is colored as a ramp from the N terminus (blue, residue 6) to the C terminus (red, residue 83). (B–D) Structural views of E. coli E-σ70. The RNAP is shown as a molecular surface except
is shown as a backbone ribbon and color-ramped according to the lower part of A. Disordered connecting segments are denoted by orange spheres. The nomenclature for the β- and β′- lineage–specific inserts (βi4, βi9, and β′i6) is as in ref. 37. (B) View into the active site channel (channel view) showing
in the channel. (C) View down through the β-subunit (β-side view), with β removed to reveal the active site (Mg2+ ion, yellow sphere) and nucleic acid binding channels. Superimposed is the DNA from an initiation complex structure (downstream portion of the transcription bubble, and 10-bp of downstream duplex DNA; PDB ID code 4G7H) (38), shown as a gray cartoon (light gray, template strand; dark gray, nontemplate strand).
occupies the downstream duplex DNA binding channel with its center of gravity at approximately +8. (D)
is nestled in the RNAP channel, interacting with elements of the β2 domain (β-residues 165–166, 197, and 202–203), the clamp (β′-residues 120, 132–133, and the rudder around residue 311), and other elements of the β′-pincer (β′-residues 1310–1311). The three methionine residues identified within
from selenomethionyl anomalous peaks (Fig. S2A) are shown (M47, M51, and M56).
Group I (primary) σs, such as E. coli σ70, are autoregulated by N-terminal σ1.1 (Fig. 1A), which serves to prevent σ70 interactions with promoter DNA in the absence of RNAP (8⇓–10). σ1.1 also plays a role in the formation of RPo (11, 12). Based on solution FRET studies, σ1.1 is located within the RNAP active center channel in E-σ70, but in RPo, σ1.1 is displaced outside the channel by the entering DNA (13). A 37-residue linker connects to the rest of σ70, facilitating the large movements of σ1.1 during RPo formation. To better understand the role of
in Gp2 inhibition of RPo formation, we determined X-ray crystal structures of E. coli RNAP holoenzyme (14) harboring full-length or Δ1.1σ70 and with or without bound Gp2. The results define the structure of E. coli
, as well as a part of the linker segment, confirm the location of
in the RNAP downstream duplex DNA channel in the holoenzyme, and demonstrate that Gp2 uses stable, specific protein–protein interactions with both the β′-jaw as well as with
to hold
in the RNAP downstream duplex DNA channel, thereby blocking entry of the promoter DNA.
Results and Discussion
We determined a series of structures of E. coli RNAP holoenzyme (the target of Gp2) with and without bound Gp2. A total of four independent structures were refined [E-Δ1.1σ70, 3.6-Å resolution; E-SelenoMethionine(SeMet)σ70, 3.9-Å resolution; Gp2–E-Δ1.1σ70, 3.9-Å resolution; and Gp2–E-σ70, 3.8-Å resolution], and diffraction datasets from an additional crystal were also analyzed (Gp2–E-SeMetσ70, 6.5-Å resolution). The highest resolution data were used for the refinement of E-Δ1.1σ70 (R/Rfree 0.246/0.288; rmsd bonds/angles 0.005 Å/1.187°; Ramachandran allowed/outliers 91.6%/0.7%). This model was then used as the starting point for refinement of the other models to equal or better parameters (Table S1 and Fig. S1).
Structure of E-σ70.
The structure of E-σ70 (containing full-length σ70) reveals σ1.1 in the context of the RNAP holoenzyme (Fig. 1 and Fig. S2). Whereas difference Fourier analyses revealed strong difference density corresponding to (Fig. S2 A and B), the electron density lacked features for most side chains, consistent with the dynamic nature of
during transcription initiation (13).
was modeled primarily as a poly-Ala backbone but with selected side chains as the density features allowed (i.e., side chains that, for the most part, interact with the RNAP). The sequence register was confirmed with the aid of the NMR structure of the structurally homologous Thermatoga maritima
[Protein Data Bank (PDB) ID code 2K6X] (10). In addition, anomalous Fourier difference maps revealed 44 of a possible 50 SeMet sites in the two copies of SeMet-σ70 in the crystallographic asymmetric unit, including six peaks attributed to methionines at positions 47, 51, and 56 in the two crystallographically independent copies of
(Fig. S2 and Table S2). Although the overall fold of much of our
model is roughly consistent with a recently published structure of E-σ70 (PDB ID code 4IGC) (15), the folds deviate after the first methionine at position 47; the positions of methionines 51 and 56 in 4IGC are not consistent with anomalous Fourier peaks attributed to methionines 51 and 56 in our structure (Fig. S2 A and B).
comprises a core folded domain (residues 1–56) of three α-helices with similar topology to Tma
(Fig. 1 and Fig. S2) (10).
is linked to the N-terminal residue of the
domain (residue 94 at the beginning of σ70 conserved region 1.2) (16, 17) by a 37-residue linker (residues 57–93) predicted to be mostly unstructured but with a weakly predicted α-helix (residues 74–80; Fig. S3) (18). The electron density maps contain difference density that is not accounted for by the
core (Fig. S2A), including an α-helical segment that we attribute to the linker helix (18). We could not confidently assign the sequence register of the linker segment, but based on correspondence between the observed and predicted α-helix and the location of the α-helical density, we attribute the linker density to roughly residues 64–83. The linker segment wraps around the
core domain, with the linker helix interacting in the groove between α-helices 1 and 3 of the core domain to form a four-helix bundle (Fig. 1).
The resulting globular structural unit formed by and the linker sits directly in the path of the downstream duplex DNA in the RNAP active site channel, with its center of gravity ∼45 Å from the RNAP active site Mg2+ ion, corresponding to the location of base-pair +8, very close to the position (+9) proposed by FRET measurements (Fig. 1C) (13). The
structural unit contacts elements of both the β-pincer (β2 domain) and the β′-pincer from the inside of the RNAP active site channel (Fig. 1D).
Structure of Gp2–RNAP Complexes.
In all four crystallographically independent complexes from the Gp2–E-Δ1.1σ70 and Gp2–E-σ70 structures, the Gp2–RNAP contacts are essentially identical (Fig. 2 and Fig. S4). As expected, Gp2 interacts primarily with the β′-jaw as well as with some residues linking the β′-jaw to the rest of the RNAP, burying an accessible surface area of about 2,100 Å2 with β′. The Gp2–β′ interface includes five potential salt bridges (Gp2–β′: E28–R1149, D37–R1174, E44–K1170, R56–E1188, and R58–E1158; Fig. 2B). The charged residues participating in these salt bridges are all well conserved among Gp2 homologs and their cognate RNAPs (Fig. S4) (19). The Gp2–β′ R56–E1188 and R58–E1158 interactions are critical for Gp2 binding to, and inhibition of, RNAP (4, 6).
Structure of Gp2–E-σ70. (A) Overall structure, showing the channel view (same view as Fig. 1B). The RNAP is shown as a molecular surface except the β′-jaw (magenta) and (orange) are shown as backbone ribbons with transparent molecular surfaces, as is Gp2 (green) sandwiched between them. Gp2 forms significant protein–protein interfaces with both β′-jaw and
, serving as a bridge between them. (B) View of the
-jaw protein–protein–protein interaction, viewed from the RNAP active site outwards. The proteins are shown as backbone worms, with selected interacting side chains highlighted (also see Fig. S4). Note the preponderance of hydrophobic interactions in the
interface, and the five salt bridges characterizing the relatively polar Gp2–β′-jaw interface. Also shown is a segment of the β2 domain that interacts with Gp2.
Gp2 also contacts residues from the β2 domain of the β-pincer (Fig. 2 and Fig. S4). Thus, Gp2 bridges the β′- and β-pincers from inside the RNAP active site channel, explaining how the presence of Gp2 favors the closed clamp state of RNAP in solution (20).
Gp2 binds to the β′-jaw and thereby occupies the downstream duplex DNA-binding channel of the RNAP (Fig. S5), but Gp2 inhibits E-Δ1.1σ70 only very inefficiently (5, 7). In the presence of Gp2, in the RNAP active site channel must move to accommodate Gp2 due to a steric clash (Fig. 3A). The Gp2–E-σ70 structure reveals that
not only moves from its normal position in E-σ70 (Fig. 1), but reorients and forms a significant protein–protein interface (buried surface area of ∼1,400 Å2) with Gp2 that is primarily hydrophobic in nature (Figs. 2 and 3A and Fig. S4). The reorientation of the
structural core, which involves a rotation of 115° and a small translation of about 4.5 Å, was confirmed by anomalous Fourier difference peaks marking the three selenomethionines in
, calculated using data from Gp2–E-SeMet
crystals (Fig. S6 and Table S1). The
structural core maintains the same structural fold in E-σ70 with or without Gp2. In the presence of Gp2, the density maps for
were somewhat better, and more side chain information was included in the model, consistent with reduced mobility due to binding to Gp2.
Gp2 reorients within the RNAP active site channel. (A) Cutaway views of the RNAP active site channel (similar to the view of Fig. 1C). (Left) E-σ70, but with the position of Gp2 (from the Gp2–E-σ70 structure) outlined (green), illustrating the steric clash between
and Gp2. (Right) Gp2–E-σ70; comparison with E-σ70 reveals the reorientation of the
structural core and the disordered
linker. (B) The
linker from E-σ70 and Gp2–σ70 were superimposed by the
structural core (orange), revealing that the
linker helix (magenta) and Gp2 (green) interact with the same hydrophobic surface of the
structural core between α-helices α1 and α3. (C) Gp2[F27BpA] cross-links to
. (Upper) Silver-stained SDS/PAGE gel showing the migration positions of β, β′, σ70, ∆1.1σ70, and Gp2[F27BpA] before (lanes 1, 3, 5, and 7) and after (lanes 2, 4, 6, and 8) UV–cross-linking. The reaction components in each lane are indicated at the top of C. (Lower) Western blot of the gel shown (Upper) with anti-Gp2 polyclonal antibodies. The Gp2[F27BpA]-σ70 complex is indicated. The expected position of the absent Gp2–Δ1.1σ70 cross-linking product is also shown.
Gp2 interacts with the same surface as the
linker helix (Fig. 3B). The linker helix and, in fact, the whole linker segment is thus entirely displaced from around the
structural core, is not accounted for by any electron density, and is presumed disordered.
Gp2 Cross-Linking and Surface Conservation.
To confirm the Gp2– protein–protein interaction, we site-specifically incorporated the nonnatural, UV–cross-linkable amino acid p-benzoyl-L-phenylalanine (BpA) (21) at position F27 of Gp2, a residue that lies near the edge of, and participates in, the
protein–protein interaction (Fig. 2B and Fig. S4) but is not highly conserved so is unlikely to be essential for the interaction (19). Moreover, phenylalanine replacement by BpA is a somewhat conservative substitution. The mutant Gp2 (Gp2[F27BpA]) was active in inhibiting E-σ70 in vitro (Fig. S7). Upon excitation with UV light, Gp2[F27BpA] in a Gp2[F27BpA]E-σ70 complex efficiently formed a specific covalent cross-link with σ70, but no detectable cross-link was formed in a Gp2[F27BpA]–E-Δ1.1σ70 with Δ1.1σ70 (Fig. 3C), indicating that the cross-link from Gp2[F27BpA] to σ70 occurred within the
domain. The strict requirements for efficient BpA cross-linking—the Cζ atom of the substituted phenylalanine residue must be within ∼2–4 Å of the carbon atom of a C-H bond (22)—make the observation of an adventitious cross-link due to close proximity of the two protein domains within the RNAP cleft unlikely. These results confirm a stable, specific protein–protein interaction between Gp2 and
.
The Gp2’s reason for being thus appears to be to anchor within the RNAP active site cleft by forming bridging protein–protein interactions between the β′-jaw and
(Figs. 2A and 3A). Support for this supposition comes from mapping conserved residues on the surface of Gp2, which reveals two distinct patches of conserved surface. One patch matches the Gp2–β′-jaw interaction interface, whereas the other patch, on the opposite face of Gp2, matches the
interaction interface (Fig. 4A).
Gp2 misappropriates for E-σ70 inhibition. (A) The interaction surfaces on Gp2 for the β′-jaw and for
are conserved among Gp2 homologs. Shown are two views of the β′-jaw–Gp2–
interacting protein triplet. Gp2 is shown as a molecular surface color-coded according to conservation (39) within an alignment of 25 Gp2 homologs (19) as shown on the color scale below. The β′-jaw (magenta) and the
structural core (gray) are shown as backbone ribbons. The interaction surfaces of the Gp2 binding partners are outlined in black on the Gp2 surface. (B) Schematic illustrating the mechanism for Gp2 inhibition of E-σ70. In E-σ70 (Upper Left),
occupies the RNAP downstream duplex DNA channel. Formation of RPo with promoter DNA causes the ejection of
from the channel (Right). In Gp2–E-σ70 (Lower Left), Gp2 (green) forms a protein bridge between β′ and
, preventing the egress of
from the channel and thereby blocking the entry of the promoter DNA.
Conclusion
Our results, combined with available functional and genetic data (4⇓⇓–7), allow a complete delineation of the mechanism for Gp2 inhibition of E. coli E-σ70 (Fig. 4B). By binding to the β′-jaw inside the RNAP active site channel, Gp2 sterically (Fig. S5) and electrostatically (6, 7) interferes with the proper positioning of DNA in the RNAP downstream duplex DNA channel. However, in the absence of , promoter DNA can effectively compete with Gp2, so Gp2 inhibition is compromised (5⇓–7). In the primary mechanism for inhibition, Gp2 forms a stable, specific protein–protein interaction with
(Figs. 2 and 3), preventing its normal egress from the RNAP active site channel (Fig. 4B). In this way, Gp2 misappropriates (23) a domain of the RNAP holoenzyme,
, to inhibit the function of the holoenzyme.
Materials and Methods
Full details of the methods used are presented in the SI Materials and Methods.
Expression and Purification of E. coli RNAP, σ70, Δ1.1σ70, and Gp2.
E.coli ΔαC-Terminal Domain (CTD)-RNAP.
For all of the structural experiments, we used E. coli core RNAP lacking the αCTD, prepared as described previously (24). The purified protein was buffer exchanged into storage buffer [10 mM Tris, pH 8.0, 0.3 M NaCl, 0.1 mM EDTA, 15% (vol/vol) glycerol, 5 mM DTT] and concentrated to 10 mg/mL by centrifugal filtration (VivaScience), and stored at −80 °C until use.
E.coli σ70 and Δ1.1σ70.
Full-length and Δ1.1 E. coli σ70 were both expressed from pET21a-based expression vectors encoding an N-terminal His6-tag followed by a PreScission protease (GE Healthcare) cleavage site. The proteins were expressed using standard methods and purified by Ni2+-affinity chromatography, protease cleavage to remove the His6-tag, anion exchange chromatography, and gel filtration chromatography. Purified σ70 or Δ1.1σ70 was concentrated to 10 mg/mL by centrifugal filtration (VivaScience) and stored at −80 °C. SeMetσ70 was produced by suppression of endogenous methionine biosynthesis (25) and purified as described for native σ70. Purified SeMetσ70 was concentrated to 5 mg/mL and stored at −80 °C.
Gp2.
T7 Gp2 was expressed and purified as described (4). Purified T7 Gp2 (in TGED + 0.5 M NaCl) was concentrated to 10 mg/mL by centrifugal filtration (VivaScience) and stored at −80 °C.
Crystallization of Complexes (E-Δ1.1σ70, E-SeMetσ70, Gp2–E-Δ1.1σ70, Gp2–E-σ70, and Gp2–E-SeMetσ70).
Before crystallization trials, aliquots of the purified components were thawed on ice and buffer-exchanged into crystallization buffer (20 mM Tris⋅HCl, pH 8.0, 0.2 M NaCl, 5 mM DTT). E-σ70 was formed by adding 1.2-fold molar excess of σ70 (or Δ1.1σ70 for E-Δ1.1σ70 or SeMetσ70 for E-SeMetσ70) to the ΔαCTD-core RNAP and incubated at room temperature for 15 min. Gp2–holoenzyme complexes were formed by adding fivefold molar excess of Gp2 to the holoenzyme and incubating at room temperature for 15 min. Before crystallization, the final concentration of complex was adjusted to 40 μM. The crystals of holoenzyme were grown via vapor diffusion at 22 °C by mixing 1 μL of sample with 1 μL of reservoir solution (0.1 M MES, pH 6, 0.1 M calcium acetate, 12–15% (vol/vol) PEG 400, 5 mM DTT) in a 48-well hanging drop tray (Hampton Research). Typically, the crystals took about 5 d to grow to a size of about 200 μm in the longest dimension. For cryoprotection, crystals were transferred into reservoir solution + 15% (vol/vol) ethylene glycol in two steps.
Data Collection, Refinement, and Model Building (E-Δ1.1σ70, E-SeMetσ70, Gp2–E-Δ1.1σ70, Gp2–E-σ70, and Gp2–E-SeMetσ70).
X-ray diffraction data were collected at Brookhaven National Laboratory National Synchrotron Light Source (NSLS) beamline X29 and at Argonne National Laboratory Advanced Photon Source (APS) beamlines 24ID-C and 24ID-E. Data were integrated and scaled using HKL2000 (26). The initial electron density maps were calculated by molecular replacement using Phaser (27) from a starting model of E. coli core RNAP (PDB ID code 3LU0) (24, 28) combined with available crystal structures of E. coli σ70 domains [, PDB ID code 1SIG (25, 29);
, PDB ID code 2P7V (4, 30)] and a homology model for the rest of σ70. Two molecules of holoenzyme were clearly identified in the asymmetric unit. The model was first refined with rigid body refinement of each RNAP molecule and subsequently of 20 individual mobile domains using Phenix (26, 31). The model was improved by iterative cycles of manual building with Coot (27, 32) and refinement with Phenix, combined with deformable elastic network refinement with noncrystallographic symmetry restraints using CNS 1.3 performed on the Structural Biology Grid cluster (33⇓–35). The final E-Δ1.1σ70 structure (3.6-Å resolution) was used as a starting model for refinement of E-SeMetσ70, Gp2–E-Δ1.1σ70, and Gp2–E-σ70, which were refined using similar methods (Table S1 and Fig. S1).
Gp2[F27BpA] Cross-Linking.
To introduce the photo–cross-linkable amino acid BpA into Gp2 at position F27, we introduced an amber stop codon TAG at position 27 using standard oligonucleotide-directed mutagenesis using plasmid pSW33:Gp2 (6), creating pSW33:Gp2(F27-TAG). The mutant Gp2 containing BpA at position F27 (Gp2[F27BpA]) was overexpressed and purified from JE1 (DE3) E. coli strain (lacking the β′-jaw domain) as previously described (6, 36) by Ni2+-affinity chromatography. The ability of the Gp2[F27BpA] to inhibit transcription by E-σ70 was confirmed using an in vitro transcription assay as previously described (6) (Fig. S7). Twenty-microliter cross-linking reactions were performed in cross-linking buffer (10 mM Tris⋅Cl, pH 8.0, 150 mM NaCl, 10% (vol/vol) glycerol, 0.1 mM EDTA, and 1 mM DTT) and comprised (as indicated in Fig. S7) 100 nM Gp2[F27BpA], 50 nM core RNAP, 200 nM σ70, and 200 nM ∆1.1σ70. The reaction was incubated at 20 °C for 5 min to allow complex formation before cross-linking was carried out at a wavelength of 365 nm in a CL-1000 UV cross-linker (UVP). The reaction was stopped after 10 min by the addition of 2× SDS/PAGE loading buffer (Sigma) and heated at 100 °C for 5 min. Samples were separated on a 15%/10% (wt/vol) split-gradient SDS/PAGE gel and proteins were visualized by silver staining. Gp2[F27BpA]-containing complexes were visualized by Western blotting using an anti-Gp2 polyclonal antibody (Eurogentec).
Acknowledgments
We thank K. R. Rajashankar and Igor Kourinov [APS Northeastern Collaborative Access Team (NE-CAT) beamlines] and W. Shi (NSLS beamline X29) for support with synchrotron data collection. This work was based, in part, on research conducted at the APS and NSLS and supported by the US Department of Energy, Office of Basic Energy Sciences. The NE-CAT beamlines at the APS are supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health (NIH). B.B. was supported by a Merck Postdoctoral Fellowship (The Rockefeller University) and a National Research Service Award (NIH F32 GM103170). The work in the laboratory of S.W. was supported by Biotechnology and Biological Sciences Research Council Project Grant BB/K000233/1.
Footnotes
- ↵1To whom correspondence should be addressed. E-mail: darst{at}rockefeller.edu.
Author contributions: B.B., S.W., and S.A.D. designed research; B.B., E.D., D.B., and E.A.C. performed research; B.B., D.B., S.W., and S.A.D. analyzed data; and B.B., E.A.C., S.W., and S.A.D. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Data deposition: The coordinates and structure factors have been deposited in the Protein Data Bank, www.pdb.org [PDB ID codes: 4LJZ (E-△1.1σ70), 4LK1 (E-SeMetσ70), 4LK0 (Gp2–E-△1.1σ70), and 4LLG (Gp2–E-σ70)].
See Commentary on page 19662.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1314576110/-/DCSupplemental.
References
- ↵
- Calendar R
- Molineux IJ
- ↵
- ↵
- ↵
- ↵
- ↵
- Cámara B,
- et al.
- ↵
- ↵
- Camarero JA,
- et al.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵Murakami KS (2013) The X-ray crystal structure of Escherichia coli RNA polymerase sigma70 holoenzyme. J Biol Chem 288(13):9126–9134.
- ↵
- ↵
- Lonetto M,
- Gribskov M,
- Gross CA
- ↵
- ↵
- Shadrin A,
- Sheppard C,
- Severinov K,
- Matthews S,
- Wigneshweraraj SR
- ↵
- Chakraborty A,
- et al.
- ↵
- Chin JW,
- Martin AB,
- King DS,
- Wang L,
- Schultz PG
- ↵
- ↵
- Hinton DM,
- et al.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Zhang Y,
- et al.
- ↵
Citation Manager Formats
Article Classifications
- Biological Sciences
- Biochemistry
See related content: